FDA Alerts
New Treatment for Diabetic Retinopathy
The U.S. Food and Drug Administration today expanded the approved use for Eylea (aflibercept) injection to treat diabetic retinopathy in patients with diabetic macular edema.
FDA Approves Eylea For Eye Disorder In Older People
The U.S. Food and Drug Administration today approved Eylea ( aflibercept ) to treat patients with wet ( neovascular ) age-related macular degeneration (AMD), a leading cause of vision loss and blindness in Americans ages 60 and older.
FDA Alerts: Avastin
The U.S. Food and Drug Administration (FDA) is alerting health care professionals that repackaged intravitreal injections of Avastin ( bevacizumab ) have caused a cluster of serious eye infections in the Miami, Florida area.